You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Advanced Bicycle Helmet Technology for Prevention of Traumatic Brain Injury
SBC: Apex Biomedical Company, LLC Topic: 106Traumatic brain injury TBI is an acquired neurological disorder that can cause long lasting disability with limited treatment options Therefore preventative strategies must be emphasized in high risk activities to reduce the individual and societal burden of this pervasive injury Bicycle activities account for of all sports related TBI with over annual injuries in the US In an e ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
A Cytomegalovirus Vectored Chagas Disease Therapeutic Vaccine
SBC: TOMEGAVAX, INC. Topic: NIAIDAbstract The goal of this project is to utilize cytomegalovirus CMV vectors to develop a therapeutic vaccine against Trypanosoma cruzi the causative agent of Chagas disease Although the most common transmission route is by a triatomine bug vector known as the kissing bug Chagas disease is also spread vertically from mother to child and along blood born routes such as organ transplant and tr ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Sensitive Single Cell PhosphoCount Platform for Drug-Insensitive Cell Detection and Combination Drug Screening for Leukemia
SBC: VIROGENOMICS BIODEVELOPMENT INC Topic: 102Project Summary All cancer patients live with the possibility that their cancer will recur and many patients develop secondary cancers as a result of treatments used for their original cancer This project addresses the problem of drug resistance and disease recurrence in cancer by leveraging unique single nanoparticle techniques to identify rare often hidden drug resistant cells in leukemia ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Mobility Rehab: A Biofeedback System for Mobility Rehabilitation for Older Adults
SBC: APDM, INC. Topic: NIAProject Summary Mobility limitations including gait and balance impairments are common in older adults and are a major cause of falls and reduced quality of life Although laboratory studies show that biofeedback during exercise training can improve motor performance physical therapists do not have access to an overground gait biofeedback system for their patients We will develop Mobility Rehab ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Ultrasensitive SERS Nano-Sensors for Pancreatic Cancer Diagnosis and Prognosis
SBC: Sanguine Diagnostics And Therapeutics, Inc. Topic: 103ABSTRACT Pancreatic cancer PC is an extremely aggressive malignancy with one of the worst prognoses of all cancers with a median survival of less than one year and an overall year survival of andlt With marked resistance to chemo and radiotherapies surgery is the only curative option In patients with localized disease and no lymph node or extra pancreatic metastases complete surgical ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Teacher Education: Promoting Reading Readiness (TEPRR)
SBC: IRIS MEDIA INC Topic: NICHDDESCRIPTIONprovided by applicantChildren who don t master the basics of literacye gphonological awarenessalphabetic awareness and letter writingvocabulary and oral languagein preschool risk failure in acquiring conventional reading skills later in elementary schoolNational Early Literacy PanelStorch et alConsidering that Head StartHSlargely serves children from minority or English learning backgro ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Mobility Life: Monitoring Mobility in Daily Lives of People with Neurological Disease
SBC: APDM, INC. Topic: NIAProject Summary Falls are the leading cause of injurieshospital visitsnursing home admissionsand reduced quality of life for people with neurological disordersAlthough there is consensus that impaired mobility is the basis for most fallsit is very di cult to evaluate these complex abilities outside a laboratory settingBrief clinical examinations do not accurately re ect dailyfunctional mobility in ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Identifying activators of interferon regulatory factors for neuroprotection
SBC: Neuralexo, LLC Topic: 106Abstract Stroke is a leading cause of morbidity and mortality in the United States However less than of patients are eligible for the current approved interventions of tissue plasminogen activator or thrombectomy We seek to develop new therapeutics to reduce the extent of damage and functional impairment resulting from ischemic injury to the brain an area of significant unmet medical need ...
STTR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
SBIR grant application to develop and commercialize a urine based medical diagnostic for the detection of bladder cancer recurrence.
SBC: Convergent Genomics, Inc. Topic: NCIDESCRIPTION provided by applicant Bladder cancer is one of the most common forms of cancer in North America Most often bladder cancer presents as superficial disease which is treatable through surgical resection but is also associated with recurrence rates of up to Thus patients must be monitored at regular intervals following resection of the tumor to assess for recurrence This moni ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
A Cytomegalovirus based therapeutic vaccine against oncogenic human papillomaviruses
SBC: TOMEGAVAX, INC. Topic: 102Abstract High risk human papillomaviruses HPV cause cervical cancer the second most common neoplasm among women globally and a large proportion of oropharyngeal cancers Although prophylactic vaccines to HPV are effective they have no therapeutic effect and thus do not benefit the millions of individuals already infected Thus there is both a medical need and a commercial opportunity for a HP ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health